0001144204-18-059492.txt : 20181113
0001144204-18-059492.hdr.sgml : 20181113
20181113214033
ACCESSION NUMBER: 0001144204-18-059492
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181108
FILED AS OF DATE: 20181113
DATE AS OF CHANGE: 20181113
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PATIENCE JOHN
CENTRAL INDEX KEY: 0001021413
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31822
FILM NUMBER: 181180103
MAIL ADDRESS:
STREET 1: 28161 N. KEITH DRIVE
CITY: LAKE FOREST
STATE: IL
ZIP: 60045
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Accelerate Diagnostics, Inc
CENTRAL INDEX KEY: 0000727207
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 841072256
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3950 S. COUNTRY CLUB ROAD #470
STREET 2: BUILDING 3-307
CITY: TUCSON
STATE: AZ
ZIP: 85714
BUSINESS PHONE: 303-863-8088
MAIL ADDRESS:
STREET 1: 3950 S. COUNTRY CLUB ROAD #470
STREET 2: BUILDING 3-307
CITY: TUCSON
STATE: AZ
ZIP: 85714
FORMER COMPANY:
FORMER CONFORMED NAME: ACCELR8 TECHNOLOGY CORP
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: HYDRO SEEK INC
DATE OF NAME CHANGE: 19880802
4
1
tv506947_4.xml
OWNERSHIP DOCUMENT
X0306
4
2018-11-08
0
0000727207
Accelerate Diagnostics, Inc
AXDX
0001021413
PATIENCE JOHN
28161 N. KEITH DRIVE
LAKE FOREST
IL
60045
1
0
1
0
Common Stock
2018-11-08
4
P
0
10000
14.96
A
39411
I
By John Patience Defined Benefit Pension Plan
Common Stock
4191211
I
By John Patience Trust dated 7/23/1993
Common Stock
2110662
I
By Patience Enterprises LP
Common Stock
44670
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.96 to $15.00, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc., any shareholder of Accelerate Diagnostics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each separate price within the range.
The reporting person disclaims beneficial ownership of these securities except in the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
/s/ Daniel M. Mahoney, attorney-in-fact
2018-11-13